Sabaa International Company for Pharmaceutical and Chemical Industry Stock
Stocks
SIPC
EGS382M1C011
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
2026-08-20
|
5-day change | 1st Jan Change | ||
| 4.730 EGP | -0.63% |
|
+1.07% | +27.15% |
| Market Cap | 1.18B 23.24M 19.91M 18.63M 17.05M 32M 2.22B 32.42M 220M 85.83M 1.12B 87.27M 85.37M 3.69B | P/E 2024 |
-18.3x | P/E 2025 | 92.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.21B 23.68M 20.29M 18.98M 17.38M 32.61M 2.27B 33.04M 224M 87.46M 1.14B 88.93M 87M 3.77B | EV / Sales 2024 |
15.8x | EV / Sales 2025 | 17.4x |
| Free-Float |
34.15% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.63% | ||
| 1 week | +1.07% | ||
| Current month | +18.55% | ||
| 1 month | +23.18% | ||
| 3 months | +36.71% | ||
| 6 months | +34.38% | ||
| Current year | +27.15% |
| 1 week | 4.61 |  | 5.5 |
| 1 month | 3.76 | | 5.5 |
| Current year | 2.8 | | 5.5 |
| 1 year | 2.62 | | 5.5 |
| 3 years | 0.62 | | 5.5 |
| 5 years | 0.62 | | 5.5 |
| 10 years | 0.34 | | 5.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.63% | +1.07% | +2.16% | +478.95% | 23.24M | |
| -0.08% | -1.53% | +16.49% | +67.63% | 47.74B | |
| -3.21% | -1.93% | +51.06% | +125.79% | 41.7B | |
| -0.40% | -1.82% | -7.37% | +15.84% | 12.14B | |
| +1.11% | -4.05% | +13.90% | +72.88% | 11.55B | |
| 0.00% | 0.00% | +30.00% | +147.62% | 9.18B | |
| -0.39% | +0.62% | +19.93% | +39.54% | 7.54B | |
| -1.35% | +1.26% | +44.30% | -11.69% | 7.35B | |
| -0.64% | -0.09% | +20.47% | +202.52% | 6.88B | |
| -5.36% | -8.72% | -34.95% | +17.39% | 5.72B | |
| Average | -1.10% | -1.83% | +15.60% | +115.65% | 14.98B | |
| Weighted average by Cap. | -1.19% | -0.77% | +24.56% | +83.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 22.78M 448K 384K 359K 328K 616K 42.84M 625K 4.24M 1.65M 21.52M 1.68M 1.64M 71.18M | 54.88M 1.08M 924K 865K 791K 1.49M 103M 1.5M 10.22M 3.98M 51.85M 4.05M 3.96M 171M |
| Net income | -18.04M -355K -304K -284K -260K -488K -33.92M -495K -3.36M -1.31M -17.04M -1.33M -1.3M -56.37M | 10.08M 198K 170K 159K 145K 273K 18.96M 277K 1.88M 732K 9.53M 744K 728K 31.51M |
| Net Debt | 30.4M 597K 512K 479K 438K 823K 57.16M 834K 5.66M 2.21M 28.72M 2.24M 2.19M 94.98M | 22.51M 443K 379K 355K 325K 609K 42.34M 617K 4.19M 1.63M 21.27M 1.66M 1.63M 70.35M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-20 | EGP 4.730 | -0.63% | 3,007,832 |
| 26-08-19 | EGP 4.760 | -5.74% | 4,334,327 |
| 26-08-18 | EGP 5.050 | -0.79% | 8,788,219 |
| 26-08-17 | EGP 5.090 | +0.39% | 30,616,225 |
| 26-08-16 | EGP 5.070 | +8.33% | 10,012,527 |
- Stock Market
- Stocks
- SIPC Stock
Select your edition
All financial news and data tailored to specific country editions
